Tradestie Institutional Equity Comparison Engine

NUVB vs LYEL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

LYEL Overall Edge

LYEL Captures Institutional Edge (2โ€“1 Pillars ยท 2โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Lyell Immunopharma, Inc. Common Stock (LYEL) driven by superior Momentum & Technical, Options & Structure while NUVB counters with relative strength in Growth & Margin. Fundamentally, NUVB trades at N/M Forward P/E with -61.2% operating margin (+242.6% YoY revenue) versus LYEL at N/M Forward P/E and -1341693.4% operating margin (-80.0% YoY). In options structure, NUVB sits in BREAKDOWN (26th %ile IV; Dealer Gamma Walls on Pro) against LYEL sits in SURGE (58th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
NUVB N/M vs LYEL N/M Fwd P/E
Growth & Margin Winner NUVB
Op Margin -61.2% vs -1341693.4% ยท YoY +242.6% vs -80.0%
Momentum & Technical Winner LYEL
1Y -46.9% vs -19.9% ยท 52W Pos 2% vs 18%
Options & Structure Winner LYEL
BREAKDOWN (26th %ile IV) vs SURGE (58th %ile IV)
NUVB NYSE
Nuvation Bio Inc.
Pharmaceutical Preparations
$3.80
-0.26% 1D
Market Cap $1.3B
1M Return -19.15%
1Y Return -46.85%
Forward P/E N/M
Unified AI Score
61.0 / 100 BUY
Tech 53.0 Fund 61.0 Flow 67.0 Mom 64.0
LYEL NASDAQ
Lyell Immunopharma, Inc. Common Stock
Pharmaceutical Preparations
$13.80
+1.62% 1D
Market Cap $434.8M
1M Return +47.12%
1Y Return -19.86%
Forward P/E N/M
Unified AI Score
35.1 / 100 SELL
Tech 15.0 Fund 39.0 Flow 67.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NUVB -46.85% LYEL -19.86% Spread: +26.99 pp (LYEL Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period NUVB Revenue LYEL Revenue NUVB Op. Margin LYEL Op. Margin Margin Edge
FY2019 N/A $0M N/A -15538.7% LYEL
FY2020 N/A $10M N/A -2732.6% LYEL
FY2021 N/A $10M N/A -2016.7% LYEL
FY2022 N/A $80M N/A -220.9% LYEL
FY2023 N/A $0M N/A -190006.2% LYEL
FY2024 $10M $0M -7527.3% -588123.0% NUVB
FY2025 $60M $0M -338.7% -748344.4% NUVB

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NUVB (6) vs LYEL (2)
Institutional Metric NUVB LYEL Criterion Row Winner
Market Capitalization Scale $1.3B $434.8M Larger Scale NUVB
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +242.6% -80.0% Higher Growth NUVB
Operating Margin (TTM) Profitability -61.2% -1341693.4% Higher Margin NUVB
Net Profit Margin Profitability -67.4% 0.0% Higher Margin LYEL
Return on Equity (ROE) Capital Efficiency -49.1% -97.8% Higher ROE NUVB
52-Week Range Position Momentum 2% ($4โ€“$10) 18% ($7โ€“$45) Stronger Trend LYEL
Beta / 30D Volatility Risk Regime 1.52ฮฒ ยท 55% Vol 1.62ฮฒ ยท 163% Vol Lower Realized Risk NUVB
Unified Institutional Score Composite Signal 61.0 / 100 (BUY) 35.1 / 100 (SELL) Higher Composite NUVB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NUVB vs LYEL Buy Guide
NUVB BREAKDOWN
105d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 26th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live NUVB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LYEL SURGE
7d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 58th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live LYEL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NUVB nor LYEL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.